Dysfunctional B cells: A novel target for cancer immunotherapy and diagnostics

University of Pittsburgh School of Medicine and UPMC Hillman Cancer Center scientists have discovered a novel subset of cancer-fighting immune cells that reside outside of their normal neighborhood—known as the tertiary lymphoid structure—where they become frustratingly dysfunctional when in close contact with tumors.

See also  Chewing gum releases microplastics into mouth: researchers
Total
0
Share
Need Help?